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quate proximal neck is still debated and may vary among
different grafts, a minimum is required for sealing and
excluding the AAA from the circulation.5 The presence of
accessory renal arteries in the neck may complicate this
issue.
Accessory renal arteries occur in 15% to 30% of adult
kidneys.6 Unlike main renal arteries, which arise from the
aorta laterally, accessory arteries tend to originate anteri-
orly. Blood supply to the kidney is segmental with insignif-
icant collateral circulation within the renal parenchyma
making individual branches functional end arteries.6 These
aberrant vessels can often be detected by preoperative
arteriography, spiral computed tomography (CT) scan-
ning, or magnetic resonance angiography (MRA).
Historically, these vessels were salvaged when feasible dur-
ing conventional repair of AAA if they were large and sup-
plied a distinct segment of the parenchyma.7-9
Because adequate proximal neck length is important
for proper endovascular treatment, it may be necessary to
exclude the origin of some accessory renal arteries when
the proximal neck is relatively short. Exclusion of these
arteries raises the theoretical concern of regional renal
The last decade has witnessed an unprecedented revo-
lution in the treatment of abdominal aortic aneurysms
(AAAs) using an endovascular, less invasive approach.1-4
Although the long-term durability and effectiveness
remain uncertain, this method has been embraced with
enthusiasm by both patients and their physicians.
However, not all aneurysms are anatomically suitable for
this method of repair. Morphologic features of the proxi-
mal neck and the iliac arteries may exclude patients from
this treatment modality. Although the length of an ade-
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Objective: Adequate proximal neck length is important for proper endovascular treatment of abdominal aortic
aneurysms (AAAs). Placement of endografts in AAAs with relatively short proximal necks may require covering the ori-
gin of accessory renal arteries. Exclusion of these arteries carries the theoretical concern of regional renal ischemia asso-
ciated with loss of parenchyma or worsening hypertension. We reviewed our experience with accessory renal exclusions
during endovascular AAA repair to determine the frequency and severity of complications.
Methods: Complete records were available for review on 311 of 325 consecutive patients treated with endovascular grafts
for AAAs from February 6, 1996, to March 15, 2001. The presence of accessory renal arteries was ascertained from
preoperative/intraoperative aortography or from computed tomographic scanning. Sizes of the accessories were mea-
sured by using the main renal arteries as a reference. Considerations for excluding the accessory renal arteries were
based on the likelihood of successful proximal attachment to healthy aorta, an accessory vessel whose size does not
exceed the diameter of the main renal artery, and the absence of renal disease.
Results: The mean follow-up was 11.5 months. Fifty-two accessory renal arteries were documented in 37 patients (12%),
ranging from 1 to ≥3 per patient. Of these, 26 accessory renal arteries were covered in 24 patients. Patients ranged in
age from 57 to 85 years (mean, 74.1 years), with 20 men and 4 women. The Ancure device was used in 23 patients
and the Excluder device in one. Of the accessories excluded, 22 originated above the aneurysm and 4 originated directly
from the aneurysm itself. There were no perioperative mortalities. One patient died 5 months after surgery from an
unrelated condition. There was one type I (distal) endoleak and no type II endoleaks. Five patients (21%) had segmental
renal infarction associated with the side of accessory renal artery exclusion. Only one patient with segmental infarction
had significant postoperative hypertension that resulted in changes in blood pressure medication. The blood pressure
reverted to normal 3 months later. One patient with a stenotic left main renal artery required exclusion of the acces-
sory renal artery for successful proximal attachment. Serum creatinine levels remained unchanged throughout follow-
up in all but one patient, in whom progressive postoperative renal failure developed despite normal renal flow scan,
presumably from intraoperative manipulation and contrast nephropathy.
Conclusion: Exclusion of accessory renal arteries to facilitate endovascular AAA repair appears to be well tolerated.
Long-term sequelae seem infrequent and mild. (J Vasc Surg 2001;34:878-84.)
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ischemia associated with loss of parenchyma or worsen-
ing hypertension. Current recommendations regarding
aberrant renal artery exclusion argue against covering
these arteries to preserve renal artery perfusion and pre-
vent adverse consequences.8,9 We reviewed our experi-
ence with accessory renal exclusions during
endovascular AAA repair to determine the frequency
and severity of complications.
METHODS
Complete records were available for review on 311 of
325 consecutive patients treated with endovascular grafts
for AAAs from February 6, 1996, to March 15, 2001.
The presence of accessory renal arteries was ascertained
from preoperative or preprocedure intraoperative aortog-
raphy, as well as from CT scanning with fine acquisition.
Endograft coverage of accessories was documented by
both completion angiography and follow-up CT scans.
Follow-up CT scans were obtained during the first
month postoperatively and at least yearly thereafter.
These were analyzed for evidence of renal parenchymal
infarction. Blood urea nitrogen and serum creatinine
(Cr) levels were determined before discharge and at fol-
low-up before every contrast CT scan in patients with
previously elevated values. Blood pressure measurements
in both arms and changes in blood pressure medications
were noted postoperatively and at all follow-up visits.
The endovascular procedures were performed in the
operating room by four different vascular surgeons with
the assistance of interventional radiologists in the first 2
years of the program. The procedures were performed
using 12-inch digital C-arm fluoroscopy units (Series
9600 and 9800 OEC Medical Systems, Salt Lake City,
Utah). The procedural details have been previously
reported.10,11 Patients treated before October 1999 were
part of multicenter phase II or III Food and Drug
Administration–approved clinical trials. All of these
patients signed a research consent form aproved by the
Institutional Review Board.
Determination of eligibility for endoluminal repair
was based on anatomic considerations. The two main
exclusion criteria were a proximal neck length of less than
15 mm and inadequate access through the iliac arteries.
Inclusion criteria were relaxed after the Food and Drug
Administration approval of two devices in September of
1999. This increased the proportion of patients treated
by endoluminal methods from 25% to nearly 70% in the
most recent 12-month period. Shorter necks of 8 mm or
longer have been accepted more recently.
All eligible patients underwent preoperative spiral CT
of the abdomen and pelvis with 3-mm cuts. Preprocedural
aortography was obtained routinely during the first 2 to 3
years. This was an evaluation modality required in all
phase II protocols that we participated in. More recently,
preoperative angiography has been limited to cases with
difficult anatomy, especially iliac arteries. These radio-
graphic studies were used to identify the accessory vessels
and their relative diameter to the main renal artery.
Fig 1. A, Preoperative angiogram depicting small left accessory
renal artery originating below the left main renal artery. B,
Intraoperative angiogram showing the left accessory renal artery
excluded. C, Follow-up CT scan without evidence of renal infarc-
tion after accessory exclusion.
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Decisions regarding management of identified acces-
sory renal arteries were made during preoperative plan-
ning. Consideration for excluding accessory renal arteries
was based on the likelihood of inadequate sealing without
coverage of the aberrant vessel(s). Only accessory vessels
that were smaller in diameter than the main renal artery
were considered for coverage. Patients with elevated
serum Cr levels of >2 mg/dL were rarely considered for
endovascular grafting and never for accessory arterial cov-
erage. When it was feasible, patients were informed pre-
operatively of the need to cover these vessels to achieve a
successful endovascular exclusion. The potential risks for
renal parenchymal loss and worsening hypertension were
addressed with patients, and their consents were obtained.
RESULTS
The Table summarizes the clinical characteristics. The
mean follow-up was 11.5 months. Fifty-two accessory
renal arteries were identified in 37 patients (12%), ranging
from 1 to ≥3 accessory arteries per patient. A single acces-
sory artery was the most frequent anomaly. The majority
of patients had multiple associated comorbid risk factors,
including ischemic heart disease, hypertension, and
chronic obstructive pulmonary disease. None of the
patients presented with a history of renal dysfunction
before the procedure, defined by a baseline serum Cr of
more than 2 mg/dL. The mean preoperative baseline
serum Cr was 1.07 mg/dL (range, 0.6-1.8).
Based on the likelihood of successful proximal endo-
graft attachment, 13 patients had their aberrant vessels
carefully preserved during positioning of the selected
device. The remaining 24 patients had a total of 26 acces-
sory renal arteries covered (Fig 1). The Ancure device
(Guidant Corporation, Menlo, Calif) was used in 23
patients and the Excluder (WL Gore and Associates,
Flagstaff, Ariz) device in one. A single accessory was
excluded in 22 patients, whereas two accessories were cov-
ered in two. Twenty-two accessories originated above the
aneurysm, and four originated directly from the aneurysm
itself. Two patients with excluded accessories had stenotic
arteries, one involving the left main renal and the other
involving a single accessory.
Successful exclusion of the AAA in each of these
patients was documented by intraoperative arteriography.
There were no endoleaks (type I or II) noted at that time.
No perioperative mortalities occurred in this group. There
were no immediate changes noted in serum Cr, blood
pressure, or blood pressure medications before discharge.
No patient had postoperative hematuria related to acces-
sory renal artery exclusion. The mean postoperative serum
Cr was 1.08 mg/dL (range, 0.7-2.0).
Follow-up CT scans detected segmental infarction occu-
pying <20% of the renal parenchyma in 5 of 26 patients
(21%) after exclusion. One patient had small bilateral acces-
sories covered, manifesting in a single lower pole infarct. The
other four patients had lower pole infarcts corresponding to
the side occluded. Only one patient with a small single acces-
sory occluded producing a lower pole infarct developed
Fig 2. A, Preoperative angiogram demonstrating small right acces-
sory renal artery above the aneurysm. B, Intraoperative angiogram
showing the exclusion of the right accessory renal artery. C,
Follow-up CT scan depicting a right segmental infarction.
A
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transient postoperative hypertension that required adjust-
ment in medication during follow up (Fig 2). Within 3
months, the blood pressure reverted to normal and med-
ication tapered to preoperative baseline level.
During the follow-up period, there was one death at
5 months related to a cardiac event. A distal type I
endoleak noted on the 1-month CT scan failed to resolve
spontaneously. Angiography demonstrated a patent out-
flow vessel involving a single right accessory renal artery
originating from the aneurysm (Fig 3). This was treated
with coil embolization with resolution of the endoleak. In
this patient, none of the preoperative or intraoperative
studies had identified the accessory in question. No
parenchymal infarcts were noted, nor were there eleva-
tions in blood pressure or changes in the blood pressure
medications. No type II endoleaks were discovered dur-
ing follow-up.
Cr levels remained unchanged throughout the follow-
up period in all but one patient. This patient had thinning
of the renal cortices preoperatively with a serum Cr level of
1.8 mg/dL. A small stenotic accessory renal artery was
covered during the procedure. Postoperatively, the serum
Cr level rose to 2.0 mg/dL and subsequently increased to
12 mg/dL on follow-up. This patient developed progres-
sive postoperative renal failure unrelated to the accessory
renal artery occlusion, ultimately requiring renal dialysis.
Renal flow scan revealed normal arterial perfusion, sug-
gesting a different etiology for the deterioration of renal
function.
DISCUSSION
The success of AAA exclusion is critically dependent
on secure fixation of the endograft to the proximal neck.
A neck length of 15 mm or greater has been considered
for many years to be essential for proper sealing at that
level.1,5,10,11 Although this limit has been tested by some
devices with suprarenal fixation and other endografts after
commercial release, it remains a limiting anatomic crite-
rion in a significant number of patients.5,12-14 In fact, as
much as one third of AAA patients will be excluded from
endovascular therapy because of proximal neck lengths of
<15 mm.15,16
Fig 3. A, Intraoperative angiogram without evidence of right
accessory renal artery. B, Arteriogram showing right distal type I
endoleak. Outflow vessel is the right accessory renal artery.
Clinical characteristics
n
Patients with accessory renal arteries 37 (12%)
Patients with accessory renal arteries excluded 24
Men 20
Women 4
Age (mean) 74.1
Total accessory renal arteries 52
Patients with single accessory 25
Patients with two accessories 9
Patients with three or more accessories 3
Total accessories covered 26
Patients with single accessory covered 22
Patients with two accessories covered 2
Mean Preoperative serum Cr (mg/dL) (range) 1.08 (0.6-1.8)
Mean Postoperative serum Cr (mg/dL) (range) 1.07 (0.7-2.0)
Covered patients with 
postoperative renal infarcts 5
Covered patients with postoperative 
hypertension 1
Covered patients with postoperative 
renal failure 1
Covered patients with endoleaks
Type I
Proximal 0
Distal 1
Type II 0
Mortality (follow-up) 1
A
B
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The presence of accessory renal arteries complicates
the evaluation of proximal necks. If they are to be pre-
served, they may exclude an otherwise suitable patient
from endovascular treatment of the AAA. Covering one or
more accessory renal arteries may provide the necessary
neck length for proper proximal sealing. However, sacri-
ficing a part of the renal perfusion raises the theoretical
concern of regional renal ischemia with subsequent loss of
parenchyma, worsening hypertension, or renal failure.6-8
Only a limited number of reports have documented
the exclusion of these aberrant vessels during endovascu-
lar graft repair of AAA. Kaplan et al17 documented suc-
cessful exclusion of an AAA with concomitant occlusion of
17 accessory renal artery branches in 12 patients. Small
renal infarcts were noted in follow-up in six of their
patients, despite angiographic evidence of accessory occlu-
sion during endograft repair. There was no evidence of
new-onset hypertension or changes in blood pressure
medications. No patient developed progressive renal fail-
ure requiring dialysis. One patient had a transient rise in
serum Cr level, presumably from contrast nephropathy.
No retrograde endoleaks were detected on late follow-up.
Exclusion of these vessels was based on normal preopera-
tive renal function and size of aberrant accessories less
than 3 mm.
Other reports are anecdotal. Ferko et al18 reported the
exclusion of accessories during endoluminal repair of AAA
in one patient who developed renal infarction but had no
changes in blood pressure or renal function. Dorffner et
al19 also reported exclusion of accessories during endovas-
cular repair of AAA in two patients with subsequent
parenchymal infarctions noted on follow-up.
Arguments for preservation of renal arterial perfusion
contend that sacrificing renal parenchyma is unnecessary
and unwarranted and that endoluminal repair is not recom-
mended in this setting. We propose, based on our experi-
ence, that sacrificing these accessory vessels with an
endograft is met with minimal consequences and might be
acceptable in patients with short proximal necks who would
otherwise be excluded from endovascular repair. This tech-
nique would, therefore, increase the applicability of endolu-
minal therapy for AAA to a greater population of patients.
In our decision-making about coverage of accessory
renal arteries, we have relied on the relative size of the ves-
sel compared with that of the main renal artery. We were
reluctant to cover any vessel that appeared to perfuse more
than one third of the kidney parenchyma. Although cur-
rent imaging modalities have the ability to delineate most
of the vascular renal anomalies encountered during evalu-
ation for endograft repair, they cannot provide a quantita-
tive measurement of the area perfused by the artery. How
much infarction, if any, will occur after exclusion and sub-
sequently manifest in adverse clinical sequelae is unknown.
However, there are two methods that may provide an
estimate regarding the size of the expected renal infarction
and ultimately determine whether placement of an endo-
graft is appropriate. Neither method was applied to this
study preoperatively or during the follow-up period. One
method involves nuclear imaging with radionuclide renog-
raphy, which provides assessment of differential perfusion
of the kidneys before the artery in question is sacrificed.
The other method was recently reported by Dorffner et
al,19 who uniquely combined selective renal angiography
and spiral CT to calculate the volume of renal parenchyma
perfused by each artery using a software program provided
by the CT manufacturer. Although their study size was
small, it suggests good accuracy in estimating the size of
the expected renal infarction and ultimately determining
whether placement of an endograft is suitable. Whether
these modalities are cost-effective in predicting which
patients can successfully undergo coverage without clinical
consequences is unknown and may mandate further study.
In fact, to our knowledge, there are no reports regarding
the correlation between the size of renal infarction and
deterioration of renal function. However, in general,
healthy patients with normal renal function can tolerate
the loss of considerable parenchyma without necessarily
having a significant decrease in renal function.
Surprisingly, only 5 of the 24 patients covered had
renal infarction diagnosed by CT scan during follow-up.
This is most likely because of the careful selection criteria
for vessels suitable for coverage. In these patients, the size
of the accessory renal artery was small and did not exceed
the diameter of the main renal arteries. Kaplan et al17 spec-
ulate that the low incidence of infarction may be related to
poorly understood collateral vascular supply via the renal
capsule. These insignificant collaterals may, therefore, pro-
vide enough blood flow to these segmental areas in some
patients preventing infarction. The disparity between these
patients lies in the poorly understood collateral circulation
surrounding or within the renal parenchyma.
However, the resultant relative ischemia of viable renal
parenchyma was expected to be associated with a high
incidence of hypertension. We were surprised that hyper-
tension was actually fairly uncommon and transient at
worst. This may have been because of the small mass of
ischemic tissue producing only a limited amount of renin.
In fact, only one patient developed postoperative hyper-
tension with transient elevations in her blood pressure
requiring adjustments in blood pressure medications. Her
first follow-up CT scan at 1 month depicted a segmental
(right lower pole) renal infarct corresponding to the
excluded small right accessory renal. She reverted to her
normal blood pressure medication regimen within the fol-
lowing 3-month period. Her serum Cr level was within
normal values and remained stable.
Renal failure requiring dialysis was noted in only one
patient who underwent exclusion of a small accessory. The
patient’s baseline serum Cr level was 1.8 mg/dL. The
accessory renal vessel was stenotic at its origin, and there
was no associated infarction noted on follow-up CT scans.
Several weeks after discharge, he was admitted to the
emergency department for an unrelated event but was
noted to have a serum Cr level of 12 mg/dL on evalua-
tion. Renal flow scans were obtained during follow-up
because of progressing renal failure. These scans revealed
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normal findings. He subsequently required hemodialysis.
The etiology of renal failure in this patient remains
unclear, but it was presumably a result of atheroem-
bolization to the kidneys as suggested by the postopera-
tive CT scan obtained during the 1-month follow-up.
No type II endoleaks were noted with imaging meth-
ods intraoperatively or during follow-up. The origins of
the accessory vessels were mostly from the neck with only
a few arising from the aneurysm itself. Accessory arteries
arising from the neck were intimately covered by the graft
and subsequently thrombosed. Accessories arising from
the aneurysm itself pose little threat for an endoleak
because of limited backbleeding from these arteries,
although they may become involved as an outflow for an
endoleak. One of our patients with a distal type I
endoleak that did not resolve spontaneously was noted on
angiography as having an accessory renal artery originat-
ing from the aneurysm serving as the outflow. This acces-
sory had not been identified during preoperative or
intraoperative imaging and was incidentally discovered
during coil embolization of the distal endoleak. After coil-
ing, the endoleak resolved. There were no changes in
serum blood urea nitrogen and Cr levels, blood pressure
fluctuations, or blood pressure medications. No renal
infarction was noted in follow-up CT scan. This finding
emphasizes the likelihood of underestimating the number
of accessories not identified preoperatively and excluded
during repair with minimal clinical consequences on fol-
low-up.
CONCLUSION
Complications from exclusion of accessory renal arter-
ies to facilitate endovascular AAA repair are not common.
We recommend consideration of endovascular therapy in
patients with relatively short proximal necks that may
require the sacrifice of accessory renal vessels, especially in
high-risk persons who may benefit from this form of AAA
treatment. Our criteria for exclusion are based on the like-
lihood of successful proximal attachment to healthy aorta
and an accessory artery that is smaller than the main renal
artery estimated to perfuse less than one third of the kid-
ney parenchyma on that side. Relatively normal preopera-
tive renal function is necessary to consider sacrificing any
renal parenchyma. Preservation of these vessels should be
considered in patients with renal disease, patients with
large accessory arteries, and patients with enough length
to provide successful attachment proximally to healthy
aorta.
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Dr Larry Hollier (New York, NY). Dr Rhee and his colleagues
should be congratulated for a provocative paper. I have often told
my fellows that if they want to identify problems to write papers
about, all they have to do is go back and look at the literature from
20 years ago and see the problems that we discussed about open
aneurysm repair and you can write the same papers now using
endovascular as the modifier. This paper documents what we saw in
open repair many years ago—that accessory renal arteries could
usually be suture ligated without revascularization, at least in those
patients who had normal creatinine.
For the sake of time, I will be brief with my questions. Why
embolize an accessory renal artery preoperatively since these, as you
indicated, are end organ vessels? Do you really believe that
embolization is of any benefit?
Secondly, in the patients in whom you covered the accessory
renal arteries, were any of these covered in an unplanned fashion?
In other words, did you mean to leave them open and have them
occlude accidentally?
Do you have enough information about the patients to tell us
the fate of those patients with accessory renal arteries who had ele-
vated creatinines preoperatively? In your study, you included only
those who had normal creatinine, except for one patient. Perhaps
you could tell us about the others.
You also made the comment that you no longer do routine
preoperative angiography. How do you determine your graft
length? Do you do only intraoperative angiography for the place-
ment of the endografts?
Finally, the one case that you presented where, in a postopera-
tive status, you re-entered the aneurysm sac and embolized the sac
and the accessory renal artery, how did you re-enter the sac? Was
this done by percutaneous translumbar approach? How did you get
into the sac to embolize those vessels?
Thank you.
Dr Robert Y. Rhee. Thank you, Dr Hollier. The preoperative
embolization was performed only on one patient during the early
phase of the EVT trial. We currently do not practice this technique.
In our series, no patient had inadvertent coverage of accessory renal
arteries. All of these arteries were identified prior to endograft
deployment. There were no patients included in our study with sig-
nificant renal dysfunction. The mean preoperative creatinine was
1.1 mg/dL, with no patient having a value of over 2.0 mg/dL.
Regarding your question about the sizing, we do all of our
graft size measurements preoperatively using images obtained from
a spiral CT scan. A computerized measuring process is used. We
then confirm the measurements in the operating room with an
angiogram just prior to endograft implantation. Obviously, you
need to have several graft sizes available.
In the patient who had an accessory renal artery which acted as
the outflow vessel for a type II endoleak, we entered the sac via the
distal attachment site. This was performed percutaneously using a
transfemoral approach.
Dr Richard Spence (Birmingham, Ala). Having started my
career as a transplant surgeon, I feel compelled to rise in defense of
the kidney. I am concerned about your use of the term, “relatively
safe.” I think there are absolutes in medicine, and the Hippocratic
Oath says “primum do notre,” first do no harm. You have shown
us that in one fifth of your patients, you have done harm. You have
infarcted part of the kidney, and you are telling us you use very
gross measurements of renal function, a serum creatinine or hyper-
tension. We know the natural history of development of renal dis-
ease is progressive with normal creatinines until people fall off the
cliff and suddenly they are in renal failure. Would it not be wiser to
step back and measure creatinine function in these people with cre-
atinine clearance, or some more sophisticated measures, before you
do anything else? You might avoid, then, that patient who is in
chronic renal failure and that patient who is hypertensive, which
makes up about 10% of your patient population if I calculate the
numbers correctly. Thus, you could avoid not only the real conse-
quence of infarcting a kidney, but the consequence to the patient of
changes involving chronic dialysis or hypertensive medication. My
main point is that we should not move forward hastily with “rela-
tively” safe things. We learned that about occluding hypogastrics. It
is relatively safe but, oh, so what about the colonic ischemia. We
have to be careful about the “oh, so what about” the renal ischemia
and infarction and make sure that we have sophisticated measures
and follow-up. I would encourage you to follow these patients, do
creatinine clearances before and after, and see what is going on.
Dr Rhee. I agree with you, Dr Spence. The purpose of this
report was to demonstrate that coverage of these accessory renal
arteries was indeed relatively safe, but not without consequences.
There were several patients in the study who sustained partial renal
infarctions which fortunately were not clinically significant (ie, did
not cause pain, deterioration of renal function, etc). We do attempt
to preserve the accessory renal arteries whenever possible, but if the
patient is not amenable to open repair, we feel that sacrificing an
accessory renal artery is fairly well tolerated in most instances. I also
agree that following creatinine clearance in this group of patients is
a better method of assessing renal function. Certainly, those patients
who have elevated creatinine after the procedure should be evalu-
ated with a more formal study.
Dr Sean O’Donnell (Washington, DC). I appreciated your very
thoughtful presentation. I enjoyed it. I did want to re-explore the
issue of coiling the accessory renal arteries prior to endografting. It
had been our practice that if the accessory renal artery was not incor-
porated well into this proximal seal or was part of the sac, we either,
during the marking aortogram or during the procedure itself, coiled
that because of the concern of just what you demonstrated, it acting
as an outflow for a type II endoleak. I was wondering, would you
consider certain accessory renals that were in the sac or at the edge
of the proximal seal to coil those renal arteries prior to endografting?
Dr Rhee. That is an excellent question. In the case of the patient
who had a type II endoleak via an accessory renal artery at the 1-
year follow-up visit, the small accessory renal artery was unfortu-
nately not demonstrated at the time of endograft deployment.
Thus, in that particular case, it could not be embolized preopera-
tively. However, knowing what we know now, we might consider
embolizing any accessory renal arteries originating from the sac if
they were demonstrated at the time of the procedure. It is impor-
tant to remember, however, that there has to be an inflow site for
an endoleak to occur. If the endograft is completely sealed, this phe-
nomenon theoretically should not be a problem.
Dr Frank Criado (Baltimore, Md). In fact, I wanted to expand
on that because we have seen patients with type II endoleaks with
accessory renal arteries that were covered, and I would like to remind
the group, too, that one of the cases published recently, a rupture
case after an aneurysm repair, I believe it was Rod White’s case in
fact, was blamed on a type II endoleak from an accessory renal artery.
So it can certainly be a significant issue.
The other point I wanted to bring up is that, frankly, what I
found most provocative about your presentation was that your
group now considers an 8-mm neck an unqualified “adequate neck”
for endovascular repair. It just sounds surprising to me in light of the
recent developments and concern about long-term durability and
some of the outcomes that we have seen with endovascular repair
that you had arrived at that conclusion at this point. I would like
you to comment on it.
Thank you. I enjoyed the paper.
Dr Rhee. We have been pushing the limits of endovascular repair
(for aortic neck length) only for high-risk patients with otherwise
favorable anatomy. If a patient has a short neck (less than 15 mm),
we would consider endoluminal repair only if other anatomic con-
siderations (for example, the angulation of the neck) were encour-
aging and if the patient has a prohibitive risk for open repair. In
addition, endograft deployment in short aortic necks is made possi-
ble by devices with hooks or barbs which allow it to be fixed in the
juxtarenal position. Having said that, I would like to conclude that
although these maneuvers may extend the indications for endolu-
minal AAA repair, we still advocate that if there is anatomic deter-
rence for safe and durable endovascular repair, we offer all our
patients the option for open surgery.
DISCUSSION
